Katsuichi Ohsawa
Direttore/Membro del Consiglio presso TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Profilo
Katsuichi Ohsawa has worked for Taisho Pharmaceutical Co., Ltd.
since 1984 and currently holds the position of Director & Executive Officer.
He is also currently the Director & Head-Quality Assurance at Taisho Pharmaceutical Holdings Co., Ltd.
Posizioni attive di Katsuichi Ohsawa
| Società | Posizione | Inizio |
|---|---|---|
| TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Direttore/Membro del Consiglio | 01/06/2019 |
Taisho Pharmaceutical Co., Ltd.
 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | 01/06/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Katsuichi Ohsawa
